Literature DB >> 17102774

Graft tumor necrosis factor receptor-1 protects after mouse liver transplantation whereas host tumor necrosis factor receptor-1 promotes injury.

Lars O Conzelmann1, Mark Lehnert, Michael Kremer, Zhi Zhong, Michael D Wheeler, John J Lemasters.   

Abstract

BACKGROUND: Tumor necrosis factor (TNF)-alpha is a cytokine with pleiotropic effects on the liver. The predominant hepatic receptor for TNFalpha is TNF receptor-1 (TNFR1). TNFR1 mediates liver injury after ischemia/reperfusion but is also mitogenic during hepatic regeneration. This study investigated the role of graft and host TNFR1 in early graft injury after liver transplantation in mice.
METHODS: Livers from TNFR1 deficient (TNFR1-/-) and wild type (WT) mice were transplanted into either TNFR1-/- or WT recipients in all four possible combinations after 12 hours of cold storage. After eight hours, alanine transferase (ALT), necrosis, TdT-mediated dUTP-digoxigenin nick-end labeling (TUNEL) staining, caspase-3 activation, and myeloperoxidase were determined.
RESULTS: When TNFR1-/- livers were transplanted into either WT or TNFR1-/- recipients, ALT was twofold greater than when WT donor livers were used. Necrosis and TUNEL staining also increased twofold and sevenfold, respectively, after transplantation of TNFR1-/- donor livers compared to WT. By contrast, ALT and necrosis decreased when WT or TNFR1-/- livers were transplanted into TNFR1-/- hosts compared to WT, which was associated with decreased neutrophil infiltration.
CONCLUSION: In conclusion, graft and recipient TNFR1 has opposing effects. Graft TNFR1 decreases graft injury, whereas recipient TNFR1 mediates an increase of injury associated with enhanced neutrophil infiltration. Cross-transplanting of knockout and wild-type livers provides a new means to investigate graft-host interactions during hepatic injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102774     DOI: 10.1097/01.tp.0000239190.95190.5e

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation.

Authors:  T P Theruvath; C Czerny; V K Ramshesh; Z Zhong; K D Chavin; J J Lemasters
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

2.  Endothelial nitric oxide synthase protects transplanted mouse livers against storage/reperfusion injury: Role of vasodilatory and innate immunity pathways.

Authors:  T P Theruvath; Z Zhong; R T Currin; V K Ramshesh; J J Lemasters
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

3.  Orthotopic mouse liver transplantation to study liver biology and allograft tolerance.

Authors:  Shinichiro Yokota; Shinya Ueki; Yoshihiro Ono; Naoya Kasahara; Angélica Pérez-Gutiérrez; Shoko Kimura; Osamu Yoshida; Noriko Murase; Yoshikazu Yasuda; David A Geller; Angus W Thomson
Journal:  Nat Protoc       Date:  2016-06-02       Impact factor: 13.491

Review 4.  Liver transplantation in the mouse: Insights into liver immunobiology, tissue injury, and allograft tolerance.

Authors:  Shinichiro Yokota; Osamu Yoshida; Yoshihiro Ono; David A Geller; Angus W Thomson
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

5.  Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.

Authors:  Qinlong Liu; Hasibur Rehman; Yanjun Shi; Yasodha Krishnasamy; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

Review 6.  Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.

Authors:  Kelley Núñez; Paul Thevenot; Abeer Alfadhli; Ari Cohen
Journal:  Int J Mol Sci       Date:  2018-06-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.